Cargando…
Significance of DNA Replication Licensing Proteins (MCM2, MCM5 and CDC6), p16 and p63 as Markers of Premalignant Lesions of the Uterine Cervix: Its Usefulness to Predict Malignant Potential
Cervical cancer continues to be a leading cancer among women in many parts of the world. Nation-wide screening with the Pap smear has not been implemented in India due to the lack of adequately trained cytologists. Identification of biomarkers to predict malignant potential of the identified low ris...
Autores principales: | Saritha, VN, Veena, VS, Krishna, KM Jagathnath, Somanathan, Thara, Sujathan, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844608/ https://www.ncbi.nlm.nih.gov/pubmed/29373905 http://dx.doi.org/10.22034/APJCP.2018.19.1.141 |
Ejemplares similares
-
DNA Replication Licensing Proteins for Early Detection of Lung Cancer
por: VS, Veena, et al.
Publicado: (2017) -
Origin Licensing Requires ATP Binding and Hydrolysis by the MCM Replicative Helicase
por: Coster, Gideon, et al.
Publicado: (2014) -
MCM2 - a promising marker for premalignant lesions of the lung: a cohort study
por: Tan, Dong-Feng, et al.
Publicado: (2001) -
MCM-GINS and MCM-MCM interactions in vivo visualised by bimolecular fluorescence complementation in fission yeast
por: Akman, Gökhan, et al.
Publicado: (2009) -
MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis()()
por: Issac, Marianne Samir Makboul, et al.
Publicado: (2019)